Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin

Bilirubin (BR) is the final product of haem catabolism. Disruptions along BR metabolic/transport pathways resulting from inherited disorders can increase plasma BR concentration (hyperbilirubinaemia). Unconjugated hyperbilirubinemia may induce BR accumulation in brain, potentially causing irreversib...

Descripción completa

Detalles Bibliográficos
Autores principales: Nocentini, Alessio, Bonardi, Alessandro, Pratesi, Simone, Gratteri, Paola, Dani, Carlo, Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741241/
https://www.ncbi.nlm.nih.gov/pubmed/34986721
http://dx.doi.org/10.1080/14756366.2021.2020773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741241/
https://www.ncbi.nlm.nih.gov/pubmed/34986721
http://dx.doi.org/10.1080/14756366.2021.2020773

Ejemplares similares